中國科培(01890.HK)中期純利增長35%至3.8億元 中期息0.06港元
格隆匯4月27日丨中國科培(01890.HK)公吿,截至2022年2月28日止六個月,公司收益7.03億元人民幣,同比增長41.3%;期內溢利3.8億元,同比增長35.0%;經調整EBITDA 5.14億元,同比增長34.5%,派付中期股息每股股份0.06港元。
於2022年2月28日,集團所營辦及合併入賬學校(即廣東理工學院、肇慶學校、哈爾濱石油學院及淮北理工學院)共有109,824名在校學生,而根據委託管理協議由集團營辦的馬鞍山學院則共有10,124名在校學生。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.